Showing results (1001-1010 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|June 3, 2016
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumabAndrea Rubbert-Roth, Anthony Sebba, Laura Brockwell, et al.
RMD Open|June 3, 2016
Translation of clinical problems in osteoarthritis into pathophysiological research goalsPeter M van der Kraan, Francis Berenbaum, Francisco J Blanco, et al.
RMD Open|March 1, 2016
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION studyRieke Alten, Hubert Nüßlein, Mauro Galeazzi, et al.
RMD Open|March 16, 2016
Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS)Laurent Messer, Ghada Alsaleh, Philippe Georgel, et al.
RMD Open|August 6, 2016
Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overviewÉric Toussirot, François Aubin
RMD Open|February 6, 2025
OMERACT GCA phantom project: validation of a 3D-printed ultrasound training phantom for diagnosis of giant cell arteritisTobias Schremmer, Christian Dejaco, Florian Recker, et al.
RMD Open|February 8, 2025
Influence of sacroiliac joint variation on clinical features of axial spondyloarthritis: a comparative analysisCarolina Dominguez Aleixo, Katharina Ziegeler, Sevtap Tugce Ulas, et al.
RMD Open|January 30, 2025
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension studyRene Westhovens, Kevin L Winthrop, Arthur Kavanaugh, et al.
RMD Open|January 20, 2025
EULAR standardised training model for ultrasound-guided, minimally invasive synovial tissue biopsy procedures in large and small jointsIngrid Möller, Raquel Largo, David A Bong, et al.
RMD Open|January 22, 2025
Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registryYusuke Miyazaki, Shingo Nakayamada, Hiroaki Tanaka, et al.
Pageof 197